UA89614C2 - Способ получения кальциевой соли розовастатина - Google Patents

Способ получения кальциевой соли розовастатина

Info

Publication number
UA89614C2
UA89614C2 UAA200511187A UAA200511187A UA89614C2 UA 89614 C2 UA89614 C2 UA 89614C2 UA A200511187 A UAA200511187 A UA A200511187A UA A200511187 A UAA200511187 A UA A200511187A UA 89614 C2 UA89614 C2 UA 89614C2
Authority
UA
Ukraine
Prior art keywords
production
calcium salt
rosuvastatin calcium
useful
dihydroxyhept
Prior art date
Application number
UAA200511187A
Other languages
English (en)
Ukrainian (uk)
Inventor
Джеффрі Норман Кребб
Джон Горбері
Найджел Філіп Тейлор
Original Assignee
Астразенека Юк Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0312896.4A external-priority patent/GB0312896D0/en
Application filed by Астразенека Юк Лімітед filed Critical Астразенека Юк Лімітед
Publication of UA89614C2 publication Critical patent/UA89614C2/ru

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Описан способ получения кальциевой соли (Е)-7-[4-(4-флуорфенил)-6-изопропил-2-[метил(метилсульфонил)-амино]пиримидин-5-ил]-(3R,5S)-3,5-дигидроксигепт-6-еновой кислоты, которую используют для изготовления фармацевтических препаратов, применимых для использования в лечении, среди прочего, гиперхолестеролемии, гиперлипопротеинемии и атеросклероза.
UAA200511187A 2003-06-05 2004-06-03 Способ получения кальциевой соли розовастатина UA89614C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0312896.4A GB0312896D0 (en) 2003-06-05 2003-06-05 Chemical process

Publications (1)

Publication Number Publication Date
UA89614C2 true UA89614C2 (ru) 2010-02-25

Family

ID=40651873

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200511187A UA89614C2 (ru) 2003-06-05 2004-06-03 Способ получения кальциевой соли розовастатина

Country Status (2)

Country Link
UA (1) UA89614C2 (ru)
ZA (1) ZA200509539B (ru)

Also Published As

Publication number Publication date
ZA200509539B (en) 2007-09-26

Similar Documents

Publication Publication Date Title
MXPA05013128A (es) Produccion mejorada de sal calcica de rosuvastatina.
MY135301A (en) Chemical process
DE69921855D1 (en) Kristallines bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoicacid]calcium salz
HK1092462A1 (en) Process for the manufacture of the calcium salt of rosuvastatin (e)-7-[4- (4-fluorophenyl) -6-isopropyl-2-[methyl(methylsulfonyl) amino]pyrimidin -5- yl] (3r, 5s) -3, 5-dihydroxyhept-6-enoic acid and crystalline intermediates thereof
MY142615A (en) Crystalline form of bis [ (e)-7-4(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r, 5s)-3,5-dihydroxyhept-6 -enoic acid] calcium salt
MY134902A (en) Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia
ZA200205331B (en) Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid.
NO20061324L (no) Polymorfe former av en kjent antihyperlinemisk forbindelse
AP1879A (en) Pharmaceutical compositions comprising a HMG CoA reductase inhibitor.
WO2009157014A3 (en) A process for preparing hmg-coa reductase inhibitors and intermediates
UA89614C2 (ru) Способ получения кальциевой соли розовастатина
ATE553098T1 (de) Verfahren zur herstellung von rosuvastatin- calcium
PL1704144T3 (pl) Sposób wytwarzania soli wapniowej kwasu (E)-7-[4-(4-fluorofenylo)-6-izopropylo-2-[metylo(metylosulfonylo)amino]pirymidyn-5-ylo](3R,5S)-3,5-dihydroksy-6-heptenowego
BR0307369A (pt) Uso de 4-(2-fluoro-fenil)-6-metil-2-(1-piperazinil)-tieno (2,3-d)-pirimidina para o tratamento de incontinência urinária